Comparative effectiveness research: evaluating pharmacist interventions and strategies to improve medication adherence

American Journal of Hypertension
Barry L Carter, J W Foppe van Mil

Abstract

One very effective strategy to achieve good blood pressure (BP) control in primary care is the use of physician/pharmacist collaborative management. Interventions by pharmacists in both community pharmacies and primary care clinics have been shown to significantly reduce BP by both improving medication adherence and intensifying medications. This review will evaluate the strengths and weaknesses of various health services' research study designs that assess various pharmacy interventions to improve BP control. We will also evaluate strategies to measure medication adherence used in research studies, and in some cases, clinical practice. Although poor medication adherence is a major cause of inadequate BP control, suboptimal medication regimens are often more common reasons for poor BP control in typical primary care practice. This review proposes strategies to implement stronger interventions and more robust study designs in comparative effectiveness trials that evaluate team-based care for improving BP control.

References

Dec 1, 1992·American Journal of Public Health·S SheaC K Francis
Feb 1, 1983·American Journal of Public Health·D E MoriskyC R Smith
Jul 1, 1996·Journal of the American Pharmaceutical Association : APhA·J J ParkP P Burgess
Jan 1, 1997·Journal of Clinical Epidemiology·J F Steiner, A V Prochazka
Dec 31, 1997·Annals of Internal Medicine·M Von KorffE H Wagner
Jul 29, 1998·The Annals of Pharmacotherapy·R E GrymonpreD S Sitar
Dec 31, 1998·The New England Journal of Medicine·D R BerlowitzM A Moskowitz
Feb 25, 2000·BMJ : British Medical Journal·E H Wagner
Apr 12, 2000·Family Practice·M K CampbellM Eccles
Aug 22, 2000·Progress in Cardiovascular Nursing·M T KimD M Levine
Jan 31, 2002·Health Affairs·E H WagnerA Bonomi
Feb 28, 2002·Archives of Internal Medicine·Susan A OliveriaSteven M Asch
Oct 9, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Nov 21, 2002·JAMA : the Journal of the American Medical Association·Jackson T WrightUNKNOWN African American Study of Kidney Disease and Hypertension Study Group
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Thomas BodenheimerKevin Grumbach
Dec 17, 2002·Journal of the American Pharmaceutical Association : APhA·Jové A Garção, José Cabrita
Jan 31, 2003·The Journal of Clinical Hypertension·Barry L CarterWilliam J Elliott
Feb 18, 2003·Pharmacotherapy·Jeff E BorensteinScott R Weingarten
Jul 23, 2003·Journal of Clinical Epidemiology·Gbenga OgedegbeMary E Charlson
Oct 8, 2003·Patient Education and Counseling·B L SvarstadC Claesson
Mar 11, 2004·JAMA : the Journal of the American Medical Association·Kevin Grumbach, Thomas Bodenheimer
Jun 12, 2004·Journal of the American Pharmacists Association : JAPhA·Elizabeth A ChrischillesAngela K Kuehl
Jan 12, 2005·Archives of Internal Medicine·Kari L OlsonUNKNOWN Clinical Pharmacy Cardiac Risk Service Study Group
May 11, 2005·American Journal of Hypertension·Jay P GargUNKNOWN RUSH University Hypertension Service
Sep 8, 2005·The Annals of Pharmacotherapy·J W Foppe van Mil
Apr 12, 2006·Archives of Internal Medicine·Anne-Marie AudetStephen C Schoenbaum
May 26, 2006·Implementation Science : IS·Michel WensingRichard Grol
Mar 17, 2007·Journal of General Internal Medicine·Nancy R KressinDan R Berlowitz
Sep 28, 2007·Pharmacotherapy·John A MerenichUNKNOWN Clinical Pharmacy Cardiac Risk Service Study Group
Nov 30, 2007·The Journal of Clinical Hypertension·Adam J RoseNancy R Kressin
Apr 11, 2008·The Journal of Clinical Hypertension·Barry L CarterArthur J Hartz
May 6, 2008·The Journal of Clinical Hypertension·Donald E MoriskyHarry J Ward
Jun 26, 2008·JAMA : the Journal of the American Medical Association·Beverly B GreenRobert S Thompson
Aug 4, 2009·Pharmacy World & Science : PWS·J G HugtenburgJ J Beckeringh
Oct 28, 2009·Archives of Internal Medicine·Barry L CarterPaul A James
Nov 26, 2009·Archives of Internal Medicine·Barry L CarterYinghui Xu

❮ Previous
Next ❯

Citations

Mar 20, 2013·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Ann Thompson, William Semchuk
Jan 9, 2016·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Beata Jankowska-PolańskaDonald E Morisky
Oct 30, 2013·International Journal of Clinical Pharmacy·Audrey LehmannMarie Paule Schneider
Dec 3, 2013·International Journal of Clinical Pharmacy·Stefan OttenbrosJ J de Gier
Aug 21, 2014·International Journal of Clinical Pharmacy·Julien MarquisSophie Du Pasquier
Dec 31, 2015·International Journal of Clinical Pharmacy·Tyler GumsEric Foster
Jan 13, 2012·The Journal of Clinical Hypertension·Barry L CarterBeverly B Green
Oct 4, 2017·Pharmacy : Journal of Pharmacy, Education and Practice·Wing Man Lau, Parastou Donyai
Jun 5, 2020·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Jaya MuneswaraoAshutosh Kumar Verma
Jun 10, 2011·Current Opinion in Cardiology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.